Marjan Gharagozloo
Overview
Explore the profile of Marjan Gharagozloo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gill A, Smith M, Galleguillos D, Garton T, Mace J, Gadani S, et al.
J Neuroinflammation
. 2025 Jan;
22(1):21.
PMID: 39875919
Chronic innate immune activation in the central nervous system (CNS) significantly contributes to neurodegeneration in progressive multiple sclerosis (MS). Using multiple experimental autoimmune encephalomyelitis (EAE) models, we discovered that NLRX1...
2.
Gharagozloo M, Galleguillos D, Jank L, Sotirchos E, Smith M, Garton T, et al.
Neurotherapeutics
. 2023 Jun;
20(4):1229-1240.
PMID: 37296356
Recent evidence suggests that the glucagon-like peptide-1 receptor (GLP-1R) agonists have neuroprotective activities in the CNS in animal models of Parkinson's disease, Alzheimer's disease, and multiple sclerosis (MS). This study...
3.
Kapell H, Fazio L, Dyckow J, Schwarz S, Cruz-Herranz A, Mayer C, et al.
J Clin Invest
. 2023 Jan;
133(7).
PMID: 36719741
Multiple sclerosis (MS) is a progressive inflammatory demyelinating disease of the CNS. Increasing evidence suggests that vulnerable neurons in MS exhibit fatal metabolic exhaustion over time, a phenomenon hypothesized to...
4.
Gharagozloo M, Mace J, Calabresi P
Front Mol Neurosci
. 2022 Nov;
15:995477.
PMID: 36407761
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS). In people with MS, impaired remyelination and axonal loss lead to debilitating long-term...
5.
Bolourian A, Shen J, Gharagozloo M, Mojtahedi Z
Caspian J Intern Med
. 2022 Jul;
13(Suppl 3):155-160.
PMID: 35872674
Women live longer than men. Cardiovascular disorders, cancers, and serious infectious conditions are less common among women than men. Recent data also indicate that women, particularly before menopause, are less...
6.
Smith M, Chamling X, Gill A, Martinez H, Li W, Fitzgerald K, et al.
Front Mol Neurosci
. 2022 May;
15:874299.
PMID: 35600072
Astrocytes are instrumental in maintaining central nervous system (CNS) homeostasis and responding to injury. A major limitation of studying neurodegenerative diseases like multiple sclerosis (MS) is lack of human pathological...
7.
Jin J, Shneyderman M, Smith M, Gharagozloo M, Sotirchos E, Calabresi P
J Neuroimmunol
. 2022 Apr;
367:577859.
PMID: 35395486
Retinal ganglion cells (RGC) are lost as a sequela of optic nerve inflammation in myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD), but the mechanisms of injury remain incompletely understood and...
8.
Gharagozloo M, Bannon R, Calabresi P
Curr Opin Pharmacol
. 2022 Mar;
63:102194.
PMID: 35255453
Chronically demyelinated axons are rendered susceptible to degeneration through loss of trophic support from oligodendrocytes and myelin, and this process underlies disability progression in multiple sclerosis. Promoting remyelination is a...
9.
Reisi N, Esmaeil N, Gharagozloo M, Moayedi B
Clin Case Rep
. 2022 Feb;
10(1):e05293.
PMID: 35106163
Abnormal iron accumulation in vital organs is one of the major complications of β-thalassemia intermedia (β-TI). Silymarin, a flavonolignan isolated from , significantly decreases the serum ferritin levels of β-TI...
10.
Gharagozloo M, Amrani A, Wittingstall K, Hamilton-Wright A, Gris D
Front Neurosci
. 2021 Oct;
15:700253.
PMID: 34594182
Mouse behavior is a primary outcome in evaluations of therapeutic efficacy. Exhaustive, continuous, multiparametric behavioral phenotyping is a valuable tool for understanding the pathophysiological status of mouse brain diseases. Automated...